These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8488394)

  • 1. Open trial of fluoxetine therapy for premenstrual syndrome.
    Elks ML
    South Med J; 1993 May; 86(5):503-7. PubMed ID: 8488394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine in the treatment of premenstrual syndrome.
    Stone AB; Pearlstein TB; Brown WA
    Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine's spectrum of action in premenstrual syndrome.
    Menkes DB; Taghavi E; Mason PA; Howard RC
    Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
    Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
    Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term fluoxetine treatment of late luteal phase dysphoric disorder.
    Pearlstein TB; Stone AB
    J Clin Psychiatry; 1994 Aug; 55(8):332-5. PubMed ID: 8071300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.
    Shehata NAA; Moety GAFA; El Wahed HAA; Fahim AS; Katta MA; Hussein GK
    Reprod Sci; 2020 Feb; 27(2):743-750. PubMed ID: 32046452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in the treatment of premenstrual dysphoria.
    Su TP; Schmidt PJ; Danaceau MA; Tobin MB; Rosenstein DL; Murphy DL; Rubinow DR
    Neuropsychopharmacology; 1997 May; 16(5):346-56. PubMed ID: 9109106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
    Freeman EW; Sondheimer SJ; Rickels K; Albert J
    J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in the treatment of late luteal phase dysphoric disorder.
    Stone AB; Pearlstein TB; Brown WA
    J Clin Psychiatry; 1991 Jul; 52(7):290-3. PubMed ID: 2071558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine in the treatment of premenstrual syndrome.
    Ozeren S; Corakçi A; Yücesoy I; Mercan R; Erhan G
    Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):167-70. PubMed ID: 9228499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
    Stewart DE; Fairman M; Barbadoro S; Zownir P; Steiner M
    Biol Psychiatry; 1994 Aug; 36(3):201-2. PubMed ID: 7948458
    [No Abstract]   [Full Text] [Related]  

  • 14. [Premenstrual dysphoric disorder: long-term treatment with fluoxetine and discontinuation].
    de la Gándara Martín JJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(4):235-42. PubMed ID: 9412162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment.
    Pearlstein T; Joliat MJ; Brown EB; Miner CM
    Am J Obstet Gynecol; 2003 Apr; 188(4):887-95. PubMed ID: 12712081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine.
    Nazari H; Yari F; Jariani M; Marzban A; Birgandy M
    Arch Gynecol Obstet; 2013 Mar; 287(3):469-72. PubMed ID: 23073723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine treatment of premenstrual syndrome.
    Metz A
    J Clin Psychiatry; 1990 Jun; 51(6):260. PubMed ID: 2347868
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.